Table 6.

Therapeutic strategies: synthesis.

Type of Microorganism	Presence of Risk Factor in Table 7	Absence of Risk Factor in Table 7
MDR Gram-negative	Combination therapy Reports: suggesting short courses	Combination therapy Reports: suggesting short courses
ESBL-producing Gram-negative AmpC-producing Gram-negative	Combination (when feasible) therapy No clear indication in terms of duration	Combination (when feasible) therapy No clear indication in terms of duration
CP-producing Gram-negative	Combination (when feasible) therapy No clear indication in terms of duration	Combination (when feasible) therapy No clear indication in terms of duration